Navigation Links
Sunrise Biotech Holding Limited Application For Admission to PLUS
Date:11/14/2007

Holding Ltd., commented: "The Admission on the PLUS market represents a significant development for the Company which has the potential to improve its corporate governance and raise funds for its future development."

Fortunes Capital, one of the renowned financial advisory firms, has led in the listing process. Steve Wayne, president of Fortunes Capital (China), said: "Sunrise Biotech is a unique company with great potential for growth, which is one of few companies to advocate mulberry-based food and healthcare solutions. Sunrise is establishing its leading stand in this market segmentation of China biotech Industry."

Trading in the Company's shares on PLUS is expected before the end of December 2007. An announcement will be loaded onto the PLUS official website in the near future.


'/>"/>
SOURCE Sunrise Biotech Holding Limited
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email: